Despite all modern advancements in reconstructive surgery for peripheral nerve repair, recovery remains painful, frustrating, and unsatisfactory due to the absence of treatment options. Without medications or devices to support recovery after surgery for transected or severely compressed nerves, patients are often left with long term numbness, pain and loss of movement, impacting their quality of life and earning potential. Epineuron is a clinical-stage medical device company developing the first therapeutic treatment for injured peripheral nerves. The company’s lead product delivers a unique bioelectronic therapy that accelerates nerve regeneration, resulting in better and earlier overall functional recovery (movement and sensation) for patients. It’s a single-use wearable used after nerve repair surgery and has been designated a Breakthrough Device by the FDA.

Epineuron has combined cutting-edge advances in neuroscience, surgery, and biomedical engineering to create PeriPulse™ - a groundbreaking solution to deliver a novel, drug-free, bioelectronic therapy that supercharges the regeneration of damaged peripheral nerves.

Revitalizing damaged peripheral nerves with targeted electrical stimulation. Following surgical repair, a breakthrough stimulation paradigm is applied directly to the affected nerve, triggering a heightened production of vital nerve building blocks.

Designated an FDA Breakthrough device, Epineuron’s PeriPulse™ is a temporary wearable system with a shapeable electrode that delivers proprietary bioelectronic therapy for nerve regeneration. 

By offering the flexibility to deliver therapy either during or after surgery, we can provide patients with a novel treatment without disrupting standard surgical workflows or prolonging the procedure.